FIBROBIOLOGICS, INC. |
Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
| 5 USD | +5.49% |
|
-25.71% | 0.00% |
| 13/06 | FibroBiologics to Join Russell 2000 Index in July | MT |
| 14/05 | FibroBiologics, Inc. Reports Earnings Results for the First Quarter Ended March 31, 2024 | CI |
This article is reserved for members
Already a member?
Log InNot a member ?
Free registration
FibroBiologics Inc is a United States-based company. The Company operates as a biopharmaceutical company. It is focused on developing and commercializing fibroblast cell-based therapies for patients suffering from chronic diseases. It also develops biologic cures and treatments for chronic diseases, including degenerative disc disease, multiple sclerosis, wound healing, and cancer, and anti-aging extension of life applications such as thymic involution reversal and splenic involution reversal.
Calendar
27/08/2024
- Annual General Meeting
EPS Revisions
Annual profits - Rate of surprise
| 1st Jan change | Capi. | |
|---|---|---|
| 0.00% | 164M | |
| +16.73% | 123B | |
| +21.13% | 115B | |
| +18.05% | 25.85B | |
| -17.94% | 20.9B | |
| -16.24% | 16.52B | |
| -11.76% | 16.77B | |
| -44.45% | 15.56B | |
| +69.92% | 15.49B | |
| +1.41% | 13.45B |
- Stock Market
- Equities
- FBLG Stock
- News FibroBiologics, Inc.
- FibroBiologics to Join Russell 2000 Index in July
